MetaCap

Tenax Therapeutics Statistics

NASDAQ: TENXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.25-0.14 (-10.07%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Tenax Therapeutics by the numbers

Tenax Therapeutics has a market capitalization of $56.9 million based on 45.54M shares outstanding. With trailing EPS of $-1.39, Tenax Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 28.0% below its 50-day average and 86.3% below its 200-day average.

Average daily trading volume is 3.15M shares, or about $3.9 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

TENX valuation vs. peer median

TENX compared with the median of 8 peer companies
MetricTENXPeer medianDifference
Market cap$56.92M$54.89M+4%
Avg. volume3.15M122.68K+2470%

Peer median across 8 companies: IBIO, KZIA, AZR, RANI, BOLD, XLO, CTOR, XBIT.

Valuation

Price and trading

Previous close
1.39
Open
1.32
Day range
1.24 – 1.35
52-week range
1.24 – 19.40
52-week change
-84.66%
Beta
—
Volume
2.28M

Dividends and events

Annual dividend
None
Next earnings date
Aug 11, 2025

Additional statistics

Market Cap
56.92M
Forward Pe
-0.96
Eps
-1.39
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
19.40
Week52 Low
1.24
Avg Volume
3.15M
Shares Outstanding
45.54M
Ma50
1.74
Ma200
9.12
Earnings Date
Aug 11, 2025
Pct From52w High
-93.56%
Pct From52w Low
0.81%

Related